Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: a new paradigm for designer allogeneic blood and marrow transplantation.

Slides:



Advertisements
Similar presentations
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.
Advertisements

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Paulo V. Campregher, Santosh K. Srivastava, H. Joachim Deeg, Harlan S
Strategies for the Identification of T Cell–Recognized Tumor Antigens in Hematological Malignancies for Improved Graft-versus-Tumor Responses after Allogeneic Blood.
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.
by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and
Dasatinib suppresses in vitro natural killer cell cytotoxicity
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.
TCR-MHC-peptide(s): in vivo veritas
Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening by Maria S. Albano, Patricia Taylor, Robert.
Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate.
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.
Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow.
Defective B-cell-negative selection and terminal differentiation in the ICF syndrome by Carla E. Blanco-Betancourt, Anne Moncla, Michèle Milili, Yun Liang.
Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.
How I treat elderly patients with myeloma
Solid cancers after allogeneic hematopoietic cell transplantation
Nonmyeloablative conditioning for relapsed follicular lymphoma
Mutagenic potential of temozolomide in bone marrow cells in vivo
Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency by Ronald.
Tiago R. Matos, Menno A. de Rie, Marcel B.M. Teunissen 
Erythropoietin Receptor Mutations Associated With Familial Erythrocytosis Cause Hypersensitivity to Erythropoietin in the Heterozygous State by Stephanie.
Coexistence of Two Functioning T-Cell Repertoires in Healthy Ex-Thalassemics Bearing a Persistent Mixed Chimerism Years After Bone Marrow Transplantation.
T cell receptor Vβ (TCR-Vβ) expression in a drug-specific T cell line (TCL) and specificity assay of a TCL of patient P1. T cell receptor Vβ (TCR-Vβ) expression.
Altered Homeostasis of CD4+ Memory T Cells in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Chronic Graft-versus-Host Disease Enhances T Cell.
Significance of circulating T-cell clones in Sézary syndrome
Dendritic cell potentials of early lymphoid and myeloid progenitors
Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection by Katherine K. Wynn, Zara.
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral.
by Ineke J. M. ten Berge, and René A. W. van Lier
Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell–depleted stem cell transplantation.
Volume 13, Issue 2, Pages (August 2013)
Treatment of Adenovirus Disease in Stem Cell Transplant Recipients with Cidofovir  Dionissios Neofytos, Ambrish Ojha, Bijoyesh Mookerjee, John Wagner,
Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor–Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic.
Hematologic Safety Profile of Linezolid in the Early Periengraftment Period after Allogeneic Stem Cell Transplantation  Nina Cohen, Coralia N. Mihu, Susan.
Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813. Blood Volume 114(14): October.
Anergy: the CLL cell limbo
Thrombopoietin responsiveness reflects the number of doublings undergone by megakaryocyte progenitors by Jean-Michel Paulus, Najet Debili, Frédéric Larbret,
Long-Term Immune Reconstitution of Naive and Memory T Cell Pools after Haploidentical Hematopoietic Stem Cell Transplantation  Rita I. Azevedo, Maria.
Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors by Teal S. Hallstrand,
Course of disease and immune responses seen in patient LAU 672.
Comparison of Peripheral Blood Vs
Chronic graft-versus-host disease
T Cell Repertoire Development in XSCID Dogs Following Nonconditioned Allogeneic Bone Marrow Transplantation  William Vernau, Brian J. Hartnett, Douglas.
High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation.
Longitudinal Analysis of T-Cell Receptor Variable β Chain Repertoire in Patients with Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation 
Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage.
by Achille Iolascon, Hermann Heimpel, Anders Wahlin, and Hannah Tamary
A CD4 Domain 1 CC′ Loop Peptide Analogue Enhances Engraftment in a Murine Model of Bone Marrow Transplantation with Sublethal Conditioning  Gabor Varadi,
Sarah Nikiforow, Jerome Ritz 
Nasal Epithelial Cells of Donor Origin after Allogeneic Hematopoietic Cell Transplantation are Generated at a Faster Rate in the First 3 Months Compared.
Heterogeneous Clearance of Antithymocyte Globulin after CD34+-Selected Allogeneic Hematopoietic Progenitor Cell Transplantation  Irina Kakhniashvili,
Treatment with GM-CSF Secreting Myeloid Leukemia Cell Vaccine Prior to Autologous- BMT Improves the Survival of Leukemia-Challenged Mice  Jenny Zilberberg,
Normal Immunologic Response to a Neoantigen, Bacteriophage ΦX-174, in Baboons With Long-Term Lymphohematopoietic Reconstitution From Highly Purified CD34+
High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry  Kelly Buck, Kim Wadsworth, Michelle Setterholm, Martin.
Antiviral Responses following L-Leucyl-L-Leucine Methyl Esther (LLME)-Treated Lymphocyte Infusions: Graft-versus-Infection without Graft-versus-Host Disease 
Biology of Blood and Marrow Transplantation
T-Cell Receptor Vα Spectratype Analysis of a CD4-Mediated T-Cell Response against Minor Histocompatibility Antigens Involved in Severe Graft-versus-Host.
A 2-Step Approach to Peripheral Blood Haploidentical Stem Cell Transplantation for Patients with Advanced High Risk Lymphomas  Adetokunbo Folashade Oluwasanjo,
Specific donor Vβ-associated CD4+ T-cell responses correlate with severe acute graft- versus-host disease directed to multiple minor histocompatibility.
Dominant T cells in idiopathic nephrotic syndrome of childhood
Reconstitution of T Cell Subset Repertoire Diversity following Multiple Antigen- Mismatched Bone Marrow Transplantation  Thea M. Friedman, Olga Azhipa,
Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution  Maria Gendelman, Maryam Yassai,
Treatment versus Transplant for Challenging Hematologic Disorders
David A. Norris, Brian L. Kotzin  Journal of Investigative Dermatology 
Expression analysis of the C-MYB gene in T-ALL.
Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies  Mary Eapen, Paul O'Donnell,
by Honglin Chen, Paul Smith, Richard F. Ambinder, and S. Diane Hayward
Presentation transcript:

Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: a new paradigm for designer allogeneic blood and marrow transplantation by Thea M. Friedman, Kira Goldgirsh, Stephanie A. Berger, Jenny Zilberberg, Joanne Filicko-O'Hara, Neal Flomenberg, Michele Donato, Scott D. Rowley, and Robert Korngold Blood Volume 112(8):3517-3525 October 15, 2008 ©2008 by American Society of Hematology

Representative CDR3-size spectratype analysis of a Vβ family from 3 donor/patient pairs. Representative CDR3-size spectratype analysis of a Vβ family from 3 donor/patient pairs. Spectratype histograms were generated from donor PBLs, the MLC, and 2 posttransplantation samples for each Vβ shown. The area under each peak matching the PCR basepair (bp) product length is determined by the software program as described in “CDR3-size spectratype analysis” and is indicated in the table as a percentage of the total histogram. A peak within a spectratype is compared with its corresponding peak in the donor sample and is considered to be skewed (indicated in bold italics) if the percentage area is at least 2-fold that of the donor. Thea M. Friedman et al. Blood 2008;112:3517-3525 ©2008 by American Society of Hematology